Myasthenia Gravis and COVID-19: Clinical Characteristics and Outcomes

Myasthenia gravis (MG), an autoimmune neuromuscular disorder, may be a risk factor for severe COVID-19. We conducted an observational retrospective study with 15 consecutive adult MG patients admitted with COVID-19 at four hospitals in São Paulo, Brazil. Most patients with MG hospitalized for COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Camelo-Filho, Antonio E., Silva, André M. S., Estephan, Eduardo P., Zambon, Antônio A., Mendonça, Rodrigo H., Souza, Paulo V. S., Pinto, Wladimir B. V. R., Oliveira, Acary S. B., Dangoni-Filho, Iron, Pouza, Ana F. P., Valerio, Berenice C. O., Zanoteli, Edmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516054/
https://www.ncbi.nlm.nih.gov/pubmed/33013676
http://dx.doi.org/10.3389/fneur.2020.01053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516054/
https://www.ncbi.nlm.nih.gov/pubmed/33013676
http://dx.doi.org/10.3389/fneur.2020.01053

Ejemplares similares